Merck & Co Inc logo

Merck & Co Inc

€ 104.80 (0%) Nov 30
P/E:
18.32
P/B:
6.28
Market Cap:
€ 270.44B ($ 284.62B)
Enterprise V:
€ 289.01B ($ 304.16B)
Volume:
-
Avg Vol (2M):
31.00
Also Trade In:
Volume:
-
Market Cap €:
270.44B
Market Cap $:
284.62B
PE Ratio:
18.32
Avg Vol (2-Month):
31.00
Enterprise Value €:
289.01B
Enterprise Value $:
304.16B
PB Ratio:
6.28
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2023-02-03 Est.)

WBO:MRK's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 55,317.761
EPS (TTM) (€) 5.613
Beta 0
Volatility % 21.66
14-Day RSI 64.46
14-Day ATR (€) 1.277194
20-Day SMA (€) 101.065
12-1 Month Momentum % 55.7
52-Week Range (€) 63.67 - 105.2
Shares Outstanding (Mil) 2,535.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Document Form Filing Date
No Filing Data

Merck & Co Inc Analysis

Share your research